Thu 20 Aug 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Study Title | Study Sponsor | Status | Study Drug | Trial Phase | Study Protocol Number | Site |
|---|---|---|---|---|---|---|
| The effect of novel D3 use as a mouthwash in COVID-19 patients | King Faisal Specialist Hospital and Research Center (Jeddah) | Rejected | D3 mouthwash | 4 | 2022-32 | King Faisal Specialist Hospital and Research Center (Jeddah) |
| O-SEMA-Fast: A research study to understand how oral semaglutide works in people with type 2 diabetes who plan to fast during Ramadan in the United Arab Emirates, Saudi Arabia, and Kuwait | Novo Nordisk | Ongoing | Semaglutide | 4 | NN9924-757 | Almoosa Specialist Hospital (Alahsa) |
| Study on Clinical Use of EVUSHELD (AZD7442) as Pre-exposure Prophylaxis in the Real-world Setting – A Multi-centre Observational Prospective Study to Determine the Utilisation and Clinical Outcomes of EVUSHELD in Middle East and Africa | AstraZeneca | Ongoing | EVUSHELD | 4 | D8851R0000 | King Saud Medical City (Riyadh) |
| A REGISTRY TO COLLECT CHARACTERISTICS AND OUTCOMES FROM PATIENTS WITH SOLID TUMORSPROFILED WITH A NEXT-GENERATION SEQUENCINGTEST (WAYFIND-R) | Roche | Ongoing | NA | 4 | MX39897 | King Abdulaziz Medical City NG (Riyadh) |
| Real-World Experience of Upadacitinib in Moderate to Severe Atopic Dermatitis | Abbvie | Ongoing | Upadacitinib (Rinvoq) | 4 | H23-107 | King Faisal General Hospital (Makkah), Mohammed Dossary Hospital - Al Khobar, King Fahad Central Hospital (Jazan), East Jeddah General Hospital, Hira Hospital (Makkah) , Aseer Central Hospital (Abha) |
| Articaine efficacy and safety for 3 years old children: A Clinical Randomized Control Trial. | Qassim Regional Dental Center | Ongoing | Articaine | 3 | 607-43-7809 | Qassim Regional Dental Center,The One Clinic (Buraydah) |
| An open label, multi-center asciminib roll-over study to assess long-term safety in patients who have completed a Novartis sponsored asciminib study and are judged by the investigator to benefit from continued treatment. | Novartis | Ongoing | ABL001 (Asciminib), Imatinib, Nilotinib, Bosutinib | 3 | CABL001A2001B | King Faisal Specialist Hospital and Research Center (Riyadh) |
| Palbociclib Combinations in HR+/HER2- Metastatic Breast Cancer Patients: A Non-Interventional Prospective Study on the Treatment Patterns & Clinical Outcomes in Africa Middle East (PRECIOUS) | pfizer | Ongoing | PALBOCICLIB | 4 | A5481150 | King Fahad Specialist Hospital (Dammam) , King Abdulaziz Medical City NG (Riyadh) , King Khalid University Hospital (Riyadh) |
| Non-invasive ventilation and dexmedetomidine in critically ill adults: a vanguard pragmatic randomized controlled trial (inDEX trial) | King Abdullah International Medical Research Center (KAIMRC) | Ongoing | dexmedetomidine , Non-invasive ventilation | 3 | SCT22R/001/01 | King Abdulaziz Medical City NG (Riyadh) |
| A Long-Term Extension Study of Nusinersen (BIIB058) Administered at Higher Doses in Participants With Spinal Muscular Atrophy Who Previously Participated in an Investigational Study With Nusinersen | Biogen Idec Research Limited | Ongoing | Nusinersen (Spinraza) | 3 | 232SM302 | King Faisal Specialist Hospital and Research Center (Riyadh),King Fahad Specialist Hospital (Dammam),King Abdulaziz Medical City NG (Jeddah) |
Last update date: 08/05/2025 at 03:17 PM Saudi Arabia time
No feedback has been submitted for this page yet.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.